By Canadian Press

Shares in cannabis company Tilray up following U.K. supply deal with Grow Pharma

Feb 9, 2021 | 8:59 AM

NANAIMO, B.C. — Shares in cannabis company Tilray Inc. soared after the announcement of a deal with Grow Pharma to supply medical cannabis in the United Kingdom.

Tilray shares were up US$11.43 at US$41.52 in late-morning trading on the Nasdaq market.

Grow Pharma is a leading medical cannabis distributor in the United Kingdom.

Tilray, based in Nanaimo, B.C., says it expects to have a range of medical cannabis products available for patients in the United Kingdom by March.

Tilray announced a deal last year to merge with Leamington, Ont.-based Aphria Inc. 

1000 Ways to Heal

1000 Ways to Heal: Moons

Dec 10, 2024

Question of the Week

Should Mayor Reid Hamer-Jackson apologize or resign after it was found he breached a section of council's code of conduct for allowing false or misleading information to be communicated?

Dec 09, 2024

One Man's Opinion

COLLINS: Donald has it wrong - again

Dec 08, 2024

The cannabis companies have said the move will help them slash costs and give them control of the biggest slice of the Canadian retail market.

This report by The Canadian Press was first published Feb. 9, 2021.

The Canadian Press